Remote Strategic Account Liaison — ALS & Rare Neurology

Otsuka America Pharmaceutical Inc.; Boston (MA); À distance; USD 158 000 - 252 000; Plein temps

Résumé du poste

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to support the launch and growth of its Rare Neurology Franchise, focusing on ALS centers, providers, and stakeholders.

The role emphasizes communicating complex clinical data and facilitating access to therapy and patient support programs. Initial focus is on launching FUS-ALS, addressing site-of-care, patient onboarding, and reimbursement challenges, with evolution into other programs as the portfolio expands.

Qualifications

• Ability to understand complex disease states and articulate clinical data clearly.
• Educate on screening, diagnostic pathways and access programs.
• Build relationships with HCPs and Key Opinion Leaders.
• Navigate hospital purchasing, reimbursement and patient access processes.
• Present at conferences and scientific meetings to educate on rare neurology.

Responsabilités

• Educate on disease state awareness and screening pathways to prioritize appropriate patients.
• Develop and maintain relationships with ALS Centers of Excellence and other stakeholders.
• Articulate access and patient support programs to ensure positive prescribing experience.
• Collaborate with cross-functional teams to advance company objectives.
• Represent Otsuka at scientific meetings to discuss rare neurology programs.

Connaissances

Clinical acumen

HCP engagement

Conference education

Cross-functional coordination

Strategic account planning

Market access knowledge

Rare disease experience

Formation

Bachelor's Degree

Description du poste

Otsuka America Pharmaceutical Inc. is seeking a Strategic Account Liaison to support the launch and growth of its Rare Neurology Franchise, focusing on ALS centers, providers, and stakeholders.

The role emphasizes communicating complex clinical data and facilitating access to therapy and patient support programs. Initial focus is on launching FUS-ALS, addressing site-of-care, patient onboarding, and reimbursement challenges, with evolution into other programs as the portfolio expands.